Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin
Journal
The Journal of antimicrobial chemotherapy
Journal Volume
77
Journal Issue
8
Pages
2278
Date Issued
2022-07-28
Author(s)
HSIN-YI LIN
Yang, Jia Ling
Lin, Chi Ying
Huang, Sung Hsi
Abstract
The CLSI recommended high-dose daptomycin (8-12 mg/kg) for treating Enterococcus faecium bloodstream infections (BSI). The current study was designed to determine the safety and efficacy of increasing the daptomycin dose for VRE BSI patients receiving ≥8 mg/kg.
Subjects
VANCOMYCIN-RESISTANT; ENTEROCOCCUS-FAECIUM; CLINICAL-OUTCOMES; BACTEREMIA; SAFETY; COMBINATION; AMPICILLIN; FAECALIS; THERAPY; COHORT
Publisher
OXFORD UNIV PRESS
Type
journal article